Meds Apotek AB (STO:MEDS)
Sweden
· Delayed Price · Currency is SEK 26.90
-0.60 (-2.18%)
At close: Apr 27, 2026
Meds Apotek AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Revenue | 1,006 | 829.23 | 655.2 | 609 | 193.09 | Upgrade
|
| Revenue Growth (YoY) | 21.37% | 26.56% | 7.59% | 215.40% | -15.86% | Upgrade
|
| Cost of Revenue | 778.45 | 640.73 | 534.23 | 455.55 | 148.21 | Upgrade
|
| Gross Profit | 227.94 | 188.5 | 120.97 | 153.45 | 44.88 | Upgrade
|
| Selling, General & Admin | 221.79 | 183.89 | 154 | 72.98 | 25.54 | Upgrade
|
| Other Operating Expenses | -11.63 | -7.99 | -4.39 | 171.58 | 60.2 | Upgrade
|
| Operating Expenses | 230.35 | 196.65 | 170.24 | 260.01 | 89.01 | Upgrade
|
| Operating Income | -2.41 | -8.16 | -49.28 | -106.57 | -44.13 | Upgrade
|
| Interest Expense | -1.03 | -3.91 | -3.81 | -1.17 | -0.35 | Upgrade
|
| Interest & Investment Income | 0.43 | 0.95 | 1.44 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | 0.16 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | - | 0 | - | - | Upgrade
|
| Pretax Income | -3 | -11.11 | -51.48 | -107.74 | -44.47 | Upgrade
|
| Income Tax Expense | -10.73 | -0.71 | -0.46 | 1.77 | 0.34 | Upgrade
|
| Earnings From Continuing Operations | 7.73 | -10.4 | -51.02 | -109.51 | -44.81 | Upgrade
|
| Net Income to Company | 7.73 | -10.4 | -51.02 | -109.51 | -44.81 | Upgrade
|
| Net Income | 7.73 | -10.4 | -51.02 | -109.51 | -44.81 | Upgrade
|
| Net Income to Common | 7.73 | -10.4 | -51.02 | - | - | Upgrade
|
| Shares Outstanding (Basic) | 18 | 17 | 17 | - | - | Upgrade
|
| Shares Outstanding (Diluted) | 18 | 17 | 17 | - | - | Upgrade
|
| Shares Change (YoY) | 3.40% | 2.98% | - | - | - | Upgrade
|
| EPS (Basic) | 0.44 | -0.60 | -3.05 | - | - | Upgrade
|
| EPS (Diluted) | 0.43 | -0.60 | -3.05 | - | - | Upgrade
|
| Free Cash Flow | -21.83 | 19.84 | -49.78 | - | - | Upgrade
|
| Free Cash Flow Per Share | -1.22 | 1.15 | -2.97 | - | - | Upgrade
|
| Gross Margin | 22.65% | 22.73% | 18.46% | 25.20% | 23.24% | Upgrade
|
| Operating Margin | -0.24% | -0.98% | -7.52% | -17.50% | -22.85% | Upgrade
|
| Profit Margin | 0.77% | -1.25% | -7.79% | - | - | Upgrade
|
| Free Cash Flow Margin | -2.17% | 2.39% | -7.60% | - | - | Upgrade
|
| EBITDA | -0.28 | -5.96 | -46.94 | -91.11 | -40.86 | Upgrade
|
| EBITDA Margin | -0.03% | -0.72% | -7.16% | -14.96% | -21.16% | Upgrade
|
| D&A For EBITDA | 2.12 | 2.19 | 2.33 | - | - | Upgrade
|
| EBIT | -2.41 | -8.16 | -49.28 | -106.57 | -44.13 | Upgrade
|
| EBIT Margin | -0.24% | -0.98% | -7.52% | -17.50% | -22.85% | Upgrade
|
| Revenue as Reported | 1,018 | 837.39 | 659.97 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.